Bio-Thera Launches Adalimumab In China

Qletli Biosimilar Is First Chinese Humira Rival

 
• By David Wallace
  
First
Qletli is Bio-Thera’s First Launch, The Firm's First Approved Biosimilar And The First Chinese Rival To Humira • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin